Common Contracts

NEMAURA MEDICAL INC. 4,796,206 Shares of Common Stock Warrants to Purchase up to 4,796,206 Shares of Common Stock PLACEMENT AGENT AGREEMENT

Placement Agent Agreement • January 31st, 2023 • Nemaura Medical Inc. • Surgical & medical instruments & apparatus

• Contract Type
  Placement Agent Agreement
• Filed
  January 31st, 2023
• Company
  Nemaura Medical Inc.
• Industry
  Surgical & medical instruments & apparatus

Subject to the terms and conditions herein (this “Agreement”) Nemaura Medical Inc., a Nevada corporation (the “Company”), hereby agrees to sell up to an aggregate of (i) 4,796,206 (the “Shares”) of the Company’s common stock, $0.001 par value per share (the “Common Stock”) or pre-funded warrants to purchase Shares of Common Stock (the “Pre-Funded Warrants”) in lieu thereof and (ii) warrants (the “Warrants”) to purchase up to an aggregate of 4,796,206 shares of Common Stock (the “Warrant Shares”) directly to various purchasers (each, a “Purchaser” and, collectively, the “Purchasers”) through EF Hutton, division of Benchmark Investments, LLC, as Placement Agent (the “Placement Agent”). This Agreement and the documents executed and delivered by the Company and the Purchasers in connection with the Offering (as defined below), including, without limitation, a securities purchase agreement (the “Purchase Agreement”), shall be collectively referred to herein as the “Transaction Documents.” T

NOVAN, INC. 5,261,311 Units, Each Consisting of One Share of Common Stock (or Pre-Funded Warrant in lieu thereof) and a Warrant to Purchase One Share of Common Stock PLACEMENT AGENT AGREEMENT

Placement Agent Agreement • June 10th, 2022 • Novan, Inc. • Pharmaceutical preparations • New York

• Contract Type
  Placement Agent Agreement
• Filed
  June 10th, 2022
• Company
  Novan, Inc.
• Industry
  Pharmaceutical preparations
• Jurisdiction
  New York

Subject to the terms and conditions herein (this “Agreement”) Novan, Inc., a Delaware corporation (the “Company”), hereby agrees to sell up to an aggregate of (i) 5,261,311 (the “Shares”) of the Company’s common stock, $0.0001 par value per share (the “Common Stock”) or pre-funded warrants to purchase Shares of Common Stock (the “Pre-Funded Warrants”) in lieu thereof and (ii) warrants (the “Warrants”) to purchase up to an aggregate of 5,261,311 shares of Common Stock (the “Warrant Shares”) directly to various purchasers (each, a “Purchaser” and, collectively, the “Purchasers”) through Oppenheimer & Co. Inc., as Placement Agent (the “Placement Agent”). This Agreement and the documents executed and delivered by the Company and the Purchasers in connection with the Offering (as defined below), including, without limitation, a securities purchase agreement (the “Purchase Agreement”), shall be collectively referred to herein as the “Transaction Documents.” The shares of Common Stock issuabl